Medicines losing patent protection

MonthYear

January 2027

5 medicines lose their last listed patent or exclusivity in January 2027.

Jan 1Vibativtelavancin hydrochloride · Apotex Inc
Jan 3Nucyntatapentadol hydrochloride · Collegium Pharmaceutical Inc
Jan 8Provaybluemethylene blue · Provepharm SAS
Jan 19Striverdi Respimatolodaterol hydrochloride · Boehringer Ingelheim Pharmaceuticals Inc
Jan 31Nevanacnepafenac · Harrow Eye LLC

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits